Related Experiment Video
Updated: Dec 8, 2025
Author Spotlight: Advancing Corneal Innervation Research Through Innovative Models
Published on: December 8, 2023
Successful Treatment of a Pediatric Neurotrophic Keratopathy With Cenegermin
Kosmas Papadopoulos1, Volker Besgen, Walter Sekundo
1Department of Ophthalmology, Philipps University of Marburg, Faculty of Medicine, Marburg, Germany.
Purpose:
We present a challenging case of a 9-year-old patient with refractory neurotrophic keratopathy (NK) who was successfully treated with cenegermin eye drops.
Methods:
A 7-year-old boy developed an ocular infection after a visit to a public swimming pool. After having been unsuccessfully treated for 2 years with antibiotics, steroids, and artificial tears, the patient presented to our clinic with a therapy-refractory NK. We initiated treatment with autologous serum eye drops that showed only weak response. Therefore, treatment with cenegermin eye drops was started.
Results:
After cenegermin therapy, a complete restoration of the corneal surface and an increase in visual acuity were achieved.
Conclusions:
The use of cenegermin is effective in treating pediatric NK.
More Related Videos
11:13Adenoviral Gene Therapy for Diabetic Keratopathy: Effects on Wound Healing and Stem Cell Marker Expression in Human Organ-cultured Corneas and Limbal Epithelial Cells
Published on: April 7, 2016
04:00Author Spotlight: Establishing a Practical and Cost-Effective Protocol for Corneal Sensitivity Testing in Clinical Settings
Published on: August 2, 2024